Women in Pharma Leadership: Why the Step to Senior Roles Is the Hard One

Getting into pharma outsourcing is competitive. Staying visible enough to get the next promotion is harder, and it's the second problem that ends more careers than the first.

Most of the attention in this industry goes to the entry point: graduate intake, early-career pipelines, whether enough scientists are choosing CDMOs over tech. Less attention goes to the step from senior technical or operational roles into leadership, which is where representation drops off most sharply and where the reasons are least well understood.

Why career progression stalls at senior level

The skills that get someone to a senior individual contributor role are mostly legible. They show up in performance reviews, in delivered projects, in technical depth that colleagues can point to.

The skills that get someone from there into leadership are not legible in the same way. They involve being discussed favourably in rooms you're not in, being put forward before you feel ready, and being visible to people two levels above you who have no formal reason to know your name. None of that appears in a job description, and none of it is taught on the way in. Three years working towards a degree doesn't cover how to build a network or what to do with the voice insisting you're not ready.

The result is a step that people are expected to make without ever having been told what it requires.

Mentorship and sponsorship are not the same thing

The distinction matters more than it usually gets credit for, and confusing the two is common.

A mentor advises you. You go to them with a problem, they help you think it through, and the value accrues in conversations you're present for. Most organisations have some version of this, formally or informally.

A sponsor advocates for you. They use their own standing to put your name forward when opportunities come up, and the value accrues in conversations you're absent from. Sponsorship is what converts good work into promotion, because promotion decisions are made in rooms the candidate isn't in.

Mentorship is widely available. Sponsorship generally isn't, and it tends to reach the people who already have visibility or the confidence to ask. That asymmetry compounds over a career.

What CDMOs and CROs get wrong about the leadership pipeline

Three patterns come up repeatedly in the leadership searches we run.

Sponsorship is left to chance. If your senior people are having to seek sponsors out on their own initiative, the business isn't providing them. Sponsorship that only reaches the confident is a structural gap, and it shows up years later as a leadership bench thinner than it should be.

Offer processes assume negotiation. If your first offer is pitched below what you'd settle at, you're systematically paying less to whoever is least likely to push back. That's rarely distributed evenly across a workforce, and it creates a retention risk before the hire has started.

Senior hires are left without internal backing. A leader brought in to change how a site operates, then left to do it without allies, is being set up to fail regardless of how strong the appointment was. Building one or two internal relationships first does more than any mandate from above.

None of these are diversity initiatives. They're pipeline mechanics, and they affect who reaches leadership in a sector where senior operational and technical talent is already scarce.

What fourteen senior leaders said about it

Over the Elevate series, Vector Talent recorded conversations with fourteen women leading across CDMOs and CROs, from VP level through to CEO. Each covered a single career and what made the difference at the points where it could have gone either way.

Read against each other, the same three subjects kept coming up: networks built years before they were needed, confidence managed rather than waited for, and a way of leading that held up because it was genuinely their own.

Some of what they said is blunt. One describes four separate leaders telling her a decision would ruin her career, and going ahead each time. Another has never accepted a first offer and doesn't intend to start. One skipped the standard professional introduction on day one of a VP role and talked about her farm and her horses instead, and has since been named President and Chief Operating Officer of FUJIFILM Biotechnologies.

We've brought all fourteen conversations together in one document, Innovating Confidence: Women in Pharma's Secrets to Success, with the full context behind each of them.

Download your copy